Correction: Rhabdomyolysis during high dose interleukin-2 treatment of metastatic melanoma after sequential immunotherapies: a case report
==========================================================================================================================================


Clark JI, Bufalino S, Singh S, *et al*. Rhabdomyolysis during high dose interleukin-2 treatment of metastatic melanoma after sequential immunotherapies: a case report. *J Immunother Cancer* 2018;6:53. doi: 10.1186/s40425-018-0370-6

Since the online publication of this article, the authors have noticed that I. Caroline Le Poole (caroline.lepoole@northwestern.edu) is missing from the author list. The correct author list and affiliations can be found below:

Joseph I. Clark1, Shams Bufalino2, Shruti Singh1, I. Caroline Le Poole3 and Ewa Borys1 

1Cardinal Bernardin Cancer Center, Loyola University Medical Center, 2160 S 1st Avenue, Maywood, IL 60153, USA.

2Advocate Lutheran General Hospital, Park Ridge, IL, USA.

3Lurie Comprehensive Cancer Center, Northwestern University, Chicago

Additionally, the following grant acknowledgement is missing: This work was supported in part by RO1 CA191317 to ICLP.

*   © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

[http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/)
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See [http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/).